#PatientStratification
💪 Strong finish of #EASL2026 with ✨ Highlights from the MICROB-PREDICT Consensus Conference ✨ at our #Networking session - Thanks for coming 🤗!

#Microbiome-based #mechanisms #biomarkers #PatientStratification #cirrhosis #ACLF

@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
May 30, 2026 at 3:00 PM
📣 Excited to share our latest pre-print in precision medicine and molecular drug response stratification in brain tumours. [1/5] www.biorxiv.org/content/10.1...

#glioblastoma #GBM #biomarkerdiscovery #patientstratification #drugrepurposing
TP53 and RB1 are predictive genetic biomarkers for sensitivity to cytarabine in gliomas
Therapeutic progress in glioma, one of the most lethal human cancers, has been limited by molecular heterogeneity and lack of biomarker-driven drug deployment. Here we used a proprietary large-scale C...
www.biorxiv.org
November 24, 2025 at 11:39 AM
If you arere looking for #oncology data analysis for:

➡️ Drug target identification and validation
➡️ #Biomarker identification for mechanism of action or drug efficacy
➡️ Biomarker prediction for #patientstratification

We can help! Learn more at https://www.fiosgenomics.com/service/oncology
July 8, 2026 at 10:50 AM
If you arere looking for #oncology data analysis for:

➡️ Drug target identification and validation
➡️ #Biomarker identification for mechanism of action or drug efficacy
➡️ Biomarker prediction for #patientstratification

We can help! Learn more at https://www.fiosgenomics.com/service/oncology
April 29, 2026 at 1:30 PM
This study positions TFF3 as a robust #Biomarker for #BRCA #MolecularSubtyping, highlighting its #clinical utility in #PatientStratification and #therapeutic targeting in #HormoneReceptorPositive BRCA. #medsky
#OpenAccess: doi.org/10.1007/s115...
June 13, 2026 at 1:30 PM